Searching for candidate microRNA biomarkers in detection of breast cancer: A meta-analysis

Cancer Biomarkers

Volumn 13, Issue 5, 2013, Pages 395-401

  Lv, Mengmeng ^a   Zhu, Xingya ^b   Chen, Weixian ^a   Zhao, Jianhua ^a   Tang, Jinhai ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Biomarker; Breast cancer; MicroRNA; Real time PCR

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 103; MICRORNA 10B; MICRORNA 125B; MICRORNA 145; MICRORNA 155; MICRORNA 16; MICRORNA 191; MICRORNA 21; MICRORNA 222; MICRORNA 39; MICRORNA 484; MICRORNA 92A; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; GENETIC MARKER; HUMAN; META ANALYSIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

BIOMARKER; BREAST CANCER; MICRORNA; REAL TIME-PCR;

BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84892926734     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-130379     Document Type: Article

References (44)

1. N.A.K.M. Howlader N, SEERCancer Statistics Review, 1975-2008. National Cancer Institute.Bethesda, 2011. Available at. http.//seer.cancer.gov/csr/ 19752008/
2. J.G. Elmore, D.L. Miglioretti, L.M. Reisch, M.B. Barton, W. Kreuter, C.L. Christiansen, S.W. Fletcher, Screening mammograms by community radiologists. variability in false-positive rates, J Natl Cancer Inst 94 (2002) 1373-1380
3. S. Taplin, L. Abraham, W.E. Barlow, J.J. Fenton, E.A. Berns, P.A. Carney, G.R. Cutter, E.A. Sickles, D. Carl, J.G. Elmore, Mammography facility characteristics associated with interpretive accuracy of screening mammography, J Natl Cancer Inst 100 (2008) 876-887
4. M.J. Duffy, D. Evoy, E.W. McDermott, CA 15-3. uses and limitation as a biomarker for breast cancer, Clin Chim Acta (2010) 1869-1874
5. C.M. Sturgeon, M.J. Duffy, U.H. Stenman, H. Lilja, N. Brunner, D.W. Chan, R. Babaian, R.J. Bast, B. Dowell, F.J. Esteva, C. Haglund, N. Harbeck, D.F. Hayes, M. Holten-Andersen, G.G. Klee, R. Lamerz, L.H. Looijenga, R. Molina, H.J. Nielsen, H. Rittenhouse, A. Semjonow, I. Shih, P. Sibley, G. Soletormos, C. Stephan, L. Sokoll, B.R. Hoffman, E.P. Diamandis, National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers, Clin Chem 54 (2008) e11-e79
6. A.M. Cheng, M.W. Byrom, J. Shelton, L.P. Ford, Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis, Nucleic Acids Res 33 (2005) 1290-1297
7. P. Xu, M. Guo, B.A. Hay, MicroRNAs and the regulation of cell death, Trends Genet 20 (2004) 617-624
8. X. Chen, Y. Ba, L. Ma, X. Cai, Y. Yin, K. Wang, J. Guo, Y. Zhang, J. Chen, X. Guo, Q. Li, X. Li, W. Wang, Y. Zhang, J. Wang, X. Jiang, Y. Xiang, C. Xu, P. Zheng, J. Zhang, R. Li, H. Zhang, X. Shang, T. Gong, G. Ning, J. Wang, K. Zen, J. Zhang, C.Y. Zhang, Characterization of microRNAs in serum. a novel class of biomarkers for diagnosis of cancer and other diseases, Cell Res 18 (2008) 997-1006
9. P.S. Mitchell, R.K. Parkin, E.M. Kroh, B.R. Fritz, S.K. Wyman, E.L. Pogosova-Agadjanyan, A. Peterson, J. Noteboom, K.C. O'Briant, A. Allen, D.W. Lin, N. Urban, C.W. Drescher, B.S. Knudsen, D.L. Stirewalt, R. Gentleman, R.L. Vessella, P.S. Nelson, D.B.Martin,M. Tewari, Circulating microRNAs as stable blood-based markers for cancer detection, Proc Natl Acad Sci U S A 105 (2008) 10513-10518
10. O.L. Griffith, A. Melck, S.J. Jones, S.M. Wiseman, Metaanalysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers, J Clin Oncol 24 (2006) 5043-5051
11. Q.H. Zhang, H.M. Sun, R.Z. Zheng, Y.C. Li, Q. Zhang, P. Cheng, Z.H. Tang, F. Huang, Meta-Analysis of microRNA-183 family expression in human cancer studies comparing cancer tissues with noncancerous tissues, Gene (2013
12. S.K. Chan, O.L. Griffith, I.T. Tai, S.J. Jones, Meta-Analysis of colorectal cancer gene expression profiling studies identifies consistently reported candidate biomarkers, Cancer Epidemiol Biomarkers Prev 17 (2008) 543-552
13. Y. Chen, J.A. Gelfond, L.M. McManus, P.K. Shireman, Reproducibility of quantitative RT-PCR array in miRNA expression profiling and comparison with microarray analysis, BMC Genomics 10 (2009) 407
14. J.S. McDonald, D. Milosevic, H.V. Reddi, S.K. Grebe, A. Algeciras-Schimnich, Analysis of circulating microRNA. preanalytical and analytical challenges, Clin Chem 57 (2011)833-840
15. P.S. Mitchell, R.K. Parkin, E.M. Kroh, B.R. Fritz, S.K. Wyman, E.L. Pogosova-Agadjanyan, A. Peterson, J. Noteboom, K.C. O'Briant, A. Allen, D.W. Lin, N. Urban, C.W. Drescher, B.S. Knudsen, D.L. Stirewalt, R. Gentleman, R.L. Vessella, P.S. Nelson, D.B.Martin,M. Tewari, Circulating microRNAs as stable blood-based markers for cancer detection, Proc Natl Acad Sci U S A 105 (2008) 10513-10518
16. H.M. Heneghan, N. Miller, A.J. Lowery, K.J. Sweeney, J. Newell, M.J. Kerin, Circulating microRNAs as novel minimally invasive biomarkers for breast cancer, Ann Surg 251(2010) 499-505
17. W. Chen, F. Cai, B. Zhang, Z. Barekati, X.Y. Zhong, The level of circulating miRNA-10b and miRNA-373 in detecting lymph node metastasis of breast cancer. potential biomarkers, Tumour Biol 34 (2013) 455-462
18. H.M. Heneghan, N. Miller, R. Kelly, J. Newell, M.J. Kerin, Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease, Oncologist 15 (2010) 673-682
19. S. Asaga, C. Kuo, T. Nguyen, M. Terpenning, A.E. Giuliano, D.S. Hoon, Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer, Clin Chem 57(2011) 84-91
20. H. Schwarzenbach, K. Milde-Langosch, B. Steinbach, V. Muller, K. Pantel, Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients, Breast Cancer Res Treat 134 (2012) 933-941
21. R.C. Zeng, W. Zhang, X.Q. Yan, Z.Q. Ye, E.D. Chen, D.P. Huang, X.H. Zhang, G.L. Huang, Down-regulation of miRNA-30a in human plasma is a novel marker for breast cancer, Med Oncol 30 (2013) 477
22. E.K. Ng, R. Li, V.Y. Shin, H.C. Jin, C.P. Leung, E.S. Ma, R. Pang, D. Chua, K.M. Chu, W.L. Law, S.Y. Law, R.T. Poon, A. Kwong, Circulating microRNAs as specific biomarkers for breast cancer detection, PLoS One 8 (2013) e53141
23. Z. Hu, J. Dong, L.E.Wang, H. Ma, J. Liu, Y. Zhao, J. Tang, X. Chen, J. Dai, Q. Wei, C. Zhang, H. Shen, Serum microRNA profiling and breast cancer risk. the use of miR-484/191 as endogenous controls, Carcinogenesis 33 (2012) 828-834
24. F. Mar-Aguilar, C.M. Luna-Aguirre, J.C. Moreno-Rocha, J. Araiza-Chavez, V. Trevino, C. Rodriguez-Padilla, D. Resendez-Perez, Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue, Asia Pac J Clin Oncol 9 (2013) 53-59
25. F. Wang, Z. Zheng, J. Guo, X. Ding, Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor, Gynecol Oncol 119 (2010)586-593
26. X. Pan, Z.X. Wang, R. Wang, MicroRNA-21. a novel therapeutic target in human cancer, Cancer Biol Ther 10 (2010)1224-1232
27. S. Mattiske, R.J. Suetani, P.M. Neilsen, D.F. Callen, The oncogenic role of miR-155 in breast cancer, Cancer Epidemiol Biomarkers Prev 21 (2012) 1236-1243
28. D. Madhavan, K. Cuk, B. Burwinkel, R. Yang, Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures, Front Genet 4 (2013) 116
29. Q. Wu, C. Wang, Z. Lu, L. Guo, Q. Ge, Analysis of serum genome-wide microRNAs for breast cancer detection, Clin Chim Acta 413 (2012) 1058-1065
30. H.N. Appaiah, C.P. Goswami, L.A. Mina, S. Badve, G.J. Sledge, Y. Liu, H. Nakshatri, Persistent upregulation of U6.SNORD44 small RNA ratio in the serum of breast cancer patients, Breast Cancer Res 13 (2011) R86
31. E. van Schooneveld, M.C. Wouters, I. Van der Auwera, D.J. Peeters, H. Wildiers, P.A. Van Dam, I. Vergote, P.B. Vermeulen, L.Y. Dirix, S.J. Van Laere, Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with(metastatic) breast cancer and healthy volunteers, Breast Cancer Res 14 (2012) R34
32. K. Cuk, M. Zucknick, J. Heil, D. Madhavan, S. Schott, A. Turchinovich, D. Arlt, M. Rath, C. Sohn, A. Benner, H. Junkermann, A. Schneeweiss, B. Burwinkel, Circulating microRNAs in plasma as early detection markers for breast cancer, Int J Cancer 132 (2013) 1602-1612
33. S. Asaga, C. Kuo, T. Nguyen, M. Terpenning, A.E. Giuliano, D.S. Hoon, Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer, Clin Chem 57(2011) 84-91
34. M.G. Schrauder, R. Strick, R. Schulz-Wendtland, P.L. Strissel, L. Kahmann, C.R. Loehberg, M.P. Lux, S.M. Jud, A. Hartmann, A. Hein, C.M. Bayer, M.R. Bani, S. Richter, B.R. Adamietz, E. Wenkel, C. Rauh, M.W. Beckmann, P.A. Fasching, Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection, PLoS One 7(2012) e29770
35. H. Zhao, J. Shen, L. Medico, D. Wang, C.B. Ambrosone, S. Liu, A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer, PLoS One 5 (2010)e13735
36. Q. Wu, Z. Lu, H. Li, J. Lu, L. Guo, Q. Ge, Next-Generation Sequencing ofMicroRNAs for Breast Cancer Detection, Journal of Biomedicine and Biotechnology (2011
37. Y. Sun, M. Wang, G. Lin, S. Sun, X. Li, J. Qi, J. Li, Serum microRNA-155 as a potential biomarker to track disease in breast cancer, PLoS One 7 (2012) e47003
38. C. Roth, B. Rack, V. Muller, W. Janni, K. Pantel, H. Schwarzenbach, Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer, Breast Cancer Res 12 (2010) R90
39. F. Mar-Aguilar, J.A. Mendoza-Ramirez, I. Malagon-Santiago, P.K. Espino-Silva, S.K. Santuario-Facio, P. Ruiz-Flores, C. Rodriguez-Padilla, D. Resendez-Perez, Serum circulating microRNA profiling for identification of potential breast cancer biomarkers, Dis Markers 34 (2013) 163-169
40. H. Si, X. Sun, Y. Chen, Y. Cao, S. Chen, H. Wang, C. Hu, Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer, J Cancer Res Clin Oncol 139 (2013) 223-229
41. H. Wang, G. Tan, L. Dong, L. Cheng, K. Li, Z. Wang, H. Luo, Circulating MiR-125b as a marker predicting chemoresistance in breast cancer, PLoS One 7 (2012) e34210
42. J. Liu, Q. Mao, Y. Liu, X. Hao, S. Zhang, J. Zhang, Analysis of miR-205 and miR-155 expression in the blood of breast cancer patients, Chin J Cancer Res 25 (2013) 46-54
43. M. Chan, C.S. Liaw, S.M. Ji, H.H. Tan, C.Y. Wong, A.A. Thike, P.H. Tan, G.H. Ho, A.S. Lee, Identification of Circulating MicroRNA Signatures For Breast Cancer Detection, Clin Cancer Res (2013
44. B. Wang, Q. Zhang, The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors, J Cancer Res Clin Oncol 138 (2012) 1659-1666